Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial.
Circulation. Heart failure（2023）
摘要
gov; Unique Identifier: NCT01035255.
更多查看译文
关键词
B-type natriuretic peptide,angiotensin blocker-neprilysin inhibitor,clinical trial,cyclic guanosine monophosphate,heart failure
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要